This report provides exclusive insights into the COVID-19 impact on the Extracorporeal Membrane Oxygenation. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Extracorporeal Membrane Oxygenation. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Extracorporeal Membrane Oxygenation. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on
extracorporeal membrane oxygenation (ECMO) machine market provides in-depth
analysis of segments and sub-segments in the global as well as regional
extracorporeal membrane oxygenation (ECMO) machine market. The study also
highlights the impact of drivers, restraints, and macro indicators on the
global and regional extracorporeal membrane oxygenation (ECMO) machine market
over the short term as well as long term. The report is a comprehensive presentation
of trends, forecast and dollar values of global extracorporeal membrane
oxygenation (ECMO) machine market. According to the report, the global
extracorporeal membrane oxygenation (ECMO) machine market is projected to grow
at a CAGR of 4.5% over the forecast period of 2019-2025.
Extracorporeal membrane oxygenation is a life support
extracorporeal technique. It offers prolonged cardiac and respiratory support
to individuals whose heart and lungs are unable to provide an adequate gas
exchange required to sustain life. It is primarily used in heart surgeries and
can be used for long time periods.
The growing prevalence of cardiovascular and respiratory
diseases is one of the major factors contributing to the expansion of the
extracorporeal membrane oxygenation machine market. Cardiovascular disease is
the leading cause of death across the globe. As per the World Health
Organization, around 17.9 million people die due to cardiovascular diseases
globally. Additionally, chronic obstructive pulmonary disease is the third
leading cause of death worldwide. Nearly 65 million people are suffering from
COPD and around 3 million of them die every year. ECMO is applied to treat
patients with cardiac and respiratory diseases. ECMO machines provide oxygen
and remove carbon dioxide in patients when the lungs and heart fail to carry
out the blood oxygenation process. The increasing adoption of ECMO in lung
transplantation procedures led to the rise in demand for ECMO machines.
Further, the surge in the number of ECMO centers contributes to the expansion
of the ECMO machine market. The rising number of training programs about ECMO
to create awareness about the ECMO procedures contributes to the growth of the
market. In addition, increasing the geriatric population with a rising number
of people suffering from diseases stimulates the demand for the ECMO machine.
On the flip side, the high cost of ECMO procedures hinders the growth of the
ECMO machine market. Additionally, complications associated with ECMO restraint
the market growth. Moreover, technological advancement in ECMO machines creates
several growth opportunities in the global ECMO machine market.
Geographically, the global extracorporeal membrane
oxygenation machine market is segmented into North America, Asia-Pacific,
Europe, and the Rest of the World. North America is anticipated to hold a
dominant share in the global ECMO machine market. The rising prevalence of lung
cancer and the presence of a huge number of ECMO centers in the U.S. drive the
expansion of the ECMO machine market in North America. According to the
American Cancer Society, there are around 234020 new cases of lung cancer in
the United State in 2018. Asia-Pacific region has a healthy CAGR in global ECMO
machine market over the forecast period. The growth of the market in the
Asia-Pacific region is attributed to the increasing adoption of ECMO machines
in India, China and the rising prevalence of cardiovascular diseases in the
region. Europe has significant growth
opportunities in the global ECMO machine market owing to the prevalence of
cardiovascular diseases in the region and the growing healthcare industry.
The report on global extracorporeal membrane oxygenation
(ECMO) machine market covers segments such as component, modality, and
application. On the basis of component, the sub-markets include oxygenators,
cannula, accessories, controllers, and pumps. On the basis of modality, the
sub-markets include venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO.
On the basis of application, the sub-markets include cardiac applications,
respiratory applications, and extracorporeal cardiopulmonary resuscitation.
The report provides profiles of the companies in the market
such as Medtronic PLC, LivaNova PLC, Terumo Corporation, Nipro Corporation,
Getinge Group, MicroPort Scientific Corporation, Origen Biomedical, Inc.,
Xenios AG, ALung Technologies, Inc., Eurosets S.R.L., and Other companies.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of extracorporeal
membrane oxygenation (ECMO) machine market. Moreover, the study highlights
current market trends and provides forecast from 2019-2025. We also have
highlighted future trends in the market that will affect the demand during the
forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.